Work

Can We Combat Reward Deficiency Behaviors (RDS) including Substance Use Disorder (SUD) through Genetic Risk Screening coupled with Precision Pro-Dopamine Regulation by Algorithmic matched Polymorphic Allelic Risks.

Year: 2019

Type: article

Abstract: Research into the neurogenetic basis of addiction identified and characterized by Reward Deficiency Syndrome (RDS) [1] includes all drug and non-drug addictive, obsessive and compulsive behaviors.We are proposing herein that a new model for the prevention and treatment of RDS behaviors based on objective biologic evidence should be given serious consideration in the face of a drug epidemic [2].Currently, research directed toward improving treatment for highly drug-dependent patients in underserved populations represents one example of adoption of this bold concept and is under study through a NIH grant [3].The grant explores utilization of the patented Genetic Addiction Risk Score (GARS ® ) and the neuronutrient pro-dopamine regulator KB220.

Source: PubMed

Authors: Kenneth Blum, David Baron, Mary Hauser, Rajendra D Badgaiyan, B William Downs, David Siwicki, Marjorie C Gondré-Lewis

Institutions: Dominion Diagnostics (United States), Western University of Health Sciences, Icahn School of Medicine at Mount Sinai, Howard University

Language: English

Topic: Neurotransmitter Receptor Influence on Behavior

Subfield: Cellular and Molecular Neuroscience

Field: Neuroscience

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W3033906990

FWCI:

Cites: 14

Cited by:

Related to: 10